uniQure (QURE) Non-Current Assets (2015 - 2026)

uniQure (QURE) recorded quarterly Non-Current Assets of $163.0 million in Q1 2026, down 3.53% quarter-over-quarter from $168.9 million in Q4 2025, and down 4.13% on a YoY basis from $170.0 million in Q1 2025.

uniQure (QURE) Non-Current Assets (2015 - 2026) Analysis & Trends

uniQure's Non-Current Assets history runs 12 years deep, the most recent figure standing at $163.0 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 4.13% year-over-year to $163.0 million; the TTM figure through Mar 2026 stood at $163.0 million (down 4.13% YoY), while the FY2025 annual figure was $168.9 million, up 1.61% from the prior year.
  • Non-Current Assets was $163.0 million for Q1 2026 at uniQure, down from $168.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $228.2 million in Q4 2022 to a low of $138.9 million in Q2 2024.
  • Historically, Non-Current Assets has averaged $176.6 million across 5 years, with a median of $176.3 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 119.49% in 2022, then slipped 25.26% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $228.2 million in 2022, then fell by 21.19% to $179.8 million in 2023, then slipped by 7.56% to $166.2 million in 2024, then climbed by 1.61% to $168.9 million in 2025, then fell by 3.53% to $163.0 million in 2026.
  • The last three Non-Current Assets figures came in at $163.0 million (Q1 2026), $168.9 million (Q4 2025), and $172.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 162.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 162.96 Mn
Dec 31, 2025 168.92 Mn
Sep 30, 2025 172.19 Mn
Jun 30, 2025 176.32 Mn
Mar 31, 2025 169.98 Mn
Dec 31, 2024 166.25 Mn
Sep 30, 2024 181.67 Mn
Jun 30, 2024 138.88 Mn
Mar 31, 2024 174.05 Mn
Dec 31, 2023 179.84 Mn
Sep 30, 2023 177.92 Mn
Jun 30, 2023 185.81 Mn
Mar 31, 2023 188.36 Mn
Dec 31, 2022 228.19 Mn
Sep 30, 2022 173.66 Mn
Jun 30, 2022 177.91 Mn
Mar 31, 2022 178.94 Mn
Dec 31, 2021 180.94 Mn
Sep 30, 2021 180.86 Mn
Jun 30, 2021 90.04 Mn